ACOR
Connor, Clark & Lunn Investment Management (CC&L)’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,986
| Closed | -$222K | – | 1213 |
|
|
2020
Q1 | $222K | Sell |
1,986
-580
| -23% | -$64.8K | ﹤0.01% | 856 |
|
|
2019
Q4 | $628K | Sell |
2,566
-167
| -6% | -$40.9K | ﹤0.01% | 621 |
|
|
2019
Q3 | $941K | Buy |
2,733
+287
| +12% | +$98.8K | 0.01% | 556 |
|
|
2019
Q2 | $2.25M | Buy |
2,446
+334
| +16% | +$308K | 0.01% | 412 |
|
|
2019
Q1 | $3.37M | Buy |
2,112
+301
| +17% | +$480K | 0.02% | 333 |
|
|
2018
Q4 | $3.39M | Buy |
1,811
+792
| +78% | +$1.48M | 0.02% | 333 |
|
|
2018
Q3 | $2.4M | Buy |
1,019
+955
| +1,492% | +$2.25M | 0.01% | 409 |
|
|
2018
Q2 | $220K | Sell |
64
-48
| -43% | -$165K | ﹤0.01% | 946 |
|
|
2018
Q1 | $318K | Buy |
+112
| New | +$318K | ﹤0.01% | 612 |
|
|
2017
Q3 | – | Sell |
-279
| Closed | -$660K | – | 943 |
|
|
2017
Q2 | $660K | Buy |
+279
| New | +$660K | ﹤0.01% | 556 |
|
|
2016
Q1 | – | Sell |
-342
| Closed | -$1.75M | – | 916 |
|
|
2015
Q4 | $1.75M | Sell |
342
-26
| -7% | -$133K | 0.01% | 362 |
|
|
2015
Q3 | $1.17M | Buy |
+368
| New | +$1.17M | 0.01% | 372 |
|
|
2015
Q2 | – | Sell |
-79
| Closed | -$316K | – | 678 |
|
|
2015
Q1 | $316K | Sell |
79
-105
| -57% | -$420K | ﹤0.01% | 454 |
|
|
2014
Q4 | $903K | Buy |
+184
| New | +$903K | 0.01% | 315 |
|